Fair Value Calculator Fair Value Calculator
EN DE

SUCROSA (SUCROSA) Fair Value & Analysis

IN · Market cap ₹566M

S SUCROSA SUCROSA · BSE
Price₹10.90
Fair Value₹5.54
Upside-49.2%
Quality53/100
Watch SUCROSA for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹4.70 – ₹8.19

Fair value as of: Jul 6, 2026

From 26 valuation models · updated today

Share price +9.7% over the past month.

Price vs Fair Value (12 months)

₹13.88 ₹7.13 Fair Value ₹5.54 Jul 2025 Jul 2026

12‑month range ₹7.13 – ₹13.88 · fair‑value band ₹4.70 – ₹8.19 · the ₹10.90 price screens above the ₹5.54 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SUCROSA (SUCROSA) currently trades at ₹10.90, while our model-based Fair Value estimate is ₹5.54 — implying the stock looks roughly 49.2% overvalued today. We read business quality at 53/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, SUCROSA generated revenue of ₹531M at a net margin of 3.8%. Revenue grew 30.8% year over year. It earns a return on equity of 6.6%. Net debt stands at ₹415M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹4.70 (bear case) to ₹8.19 (bull case); at ₹10.90, the current price sits above that range. The share trades about 25% below its 52-week high and 60% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹531M
Revenue growth (YoY) +30.8%
Net margin 3.8%
Return on equity 6.6%
Free cash flow ₹25.4M FY2026
P/E ratio 21.0
More key figures
Operating margin 1.8%
EPS (TTM) ₹0.5200
EPS growth (YoY) -60.9%
Net debt ₹415M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

SUCROSA reported revenue of ₹531M in FY2026 versus ₹200M in FY2022, a compound +27.7%/yr. Reported net income was ₹20.0M in FY2026.

Revenue +27.7%/yr
FY22 ₹200M
FY23 ₹225M
FY24 ₹312M
FY25 ₹454M
FY26 ₹531M
Net income
FY22 −₹64.6M
FY23 ₹10.1M
FY24 ₹13.3M
FY25 ₹21.6M
FY26 ₹20.0M

Is SUCROSA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SUCROSA Fair Value". https://www.fairvalue-calculator.com/stock/SUCROSA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SUCROSA (SUCROSA) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹5.54 versus a price of ₹10.90 — about −49% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SUCROSA?
Our model-based fair value for SUCROSA is ₹5.54 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹10.90.
What is the quality score of SUCROSA?
SUCROSA has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SUCROSA (SUCROSA)?
SUCROSA reported trailing-twelve-month revenue of about ₹531M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SUCROSA?
The net profit margin of SUCROSA is about 3.8%, meaning it keeps roughly 3.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.